21 research outputs found

    EGF induces dimerization of modified EGF receptors.

    No full text
    <p>SDS-PAGE analysis of EGFR dimerization. EGFR+EGF Lane, unmodified EGF receptors with EGF present. EGFR Lane, unmodified EGF receptors without EGF present. mod. EGFR + EGF Lane, modified EGF receptors with EGF present. mod. EGFR Lane, modified EGF receptors without EGF present. EGF Lane, only EGF present (no EGF receptors present).</p

    Encapsulated drug leakage from a MLV (schematic).

    No full text
    <p>A homogeneous, spherically symmetric, drug-encapsulating MLV.</p

    MRBL-borne modified EGF receptors show binding specificity for EGF.

    No full text
    <p>Binding of [<sup>125</sup>I]EGF to MRBLs as assessed by liquid scintillation counting. Ctrl, MRBLs pre-incubated with an excess of unlabeled EGF before incubation with [<sup>125</sup>I]EGF. Expt, MRBLs not pre-incubated with an excess of unlabeled EGF before incubation with [<sup>125</sup>I]EGF.</p

    Production of liposomes in a CTR.

    No full text
    <p>Predicted concentrations of reagents and drug-encapsulating liposomes as a function of reactor position. Initial conditions used: [TR] = 500 arbitrary units (a.u.); [DRG] = 50000 a.u.; [DEL] = 0 a.u.</p

    MRBL-borne modified EGF receptor dimers interact with the MRBL lipid bilayer to increase MRBL permeability (schematic).

    No full text
    <p>Dimerization of MRBL-borne modified EGF receptors. ext. sol'n, exterior solution. EGFR, modified EGF receptors. int., interior of unilamellar MRBL. X-----, crosslinked p-toluic acid or methyl-PEO<sub>4</sub>-NHS ester.</p

    Vascular mass transfer of liposomes (schematic).

    No full text
    <p>Migration of liposomes in a blood vessel. Applicable mass transfer coefficients are shown.</p

    EGF in solution increases rate of encapsulated actinomycin D release.

    No full text
    <p>Percentage (expressed as fraction released) of encapsulated actinomycin D released as assessed by <sup>1</sup>H NMR spectroscopy. Baseline Ctrl, actinomycin D-encapsulating MRBLs without growth factor added to solution. Grth Fctr Ctrl, actinomycin D-encapsulating MRBLs with VEGF added to solution. Expt, actinomycin D-encapsulating MRBLs with EGF added to solution.</p
    corecore